XML 51 R38.htm IDEA: XBRL DOCUMENT v3.25.3
Net Loss per Share (Tables)
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Schedule of basic and diluted net loss per share attributable to ordinary shareholders
Basic and diluted net loss per share attributable to ordinary shareholders was calculated as follows (in thousands, except share and per share amounts):
Three Months Ended
September 30, 2025
Nine Months Ended
September 30, 2025
Loss AllocationWeighted Average Shares OutstandingLoss Per Share, Basic and DilutedLoss AllocationWeighted Average Shares OutstandingLoss Per Share, Basic and Diluted
Ordinary Shares$(20,947)16,540,771$(1.27)$(52,391)6,640,402$(7.89)
Company Series A Preferred Shares (1)
(3,660)2,890$(1,266.44)(9,154)1,160$(7,891.38)
Net loss$(24,607)$(61,545)
Period from September 19, 2024 (Inception) Through September 30, 2024
Loss AllocationWeighted Average Shares OutstandingLoss Per Share, Basic and Diluted
Common Stock$(2,631)730,092 $(3.60)
Net loss$(2,631)

(1) The weighted-average number of shares of as-converted Series A Preferred Shares used in the loss allocation was 2,890,000 and 1,160,219 for the three and nine months ended September 30, 2025, respectively.
Schedule of anti-dilutive net loss per share attributable to ordinary shareholders The potential ordinary shares that were excluded from the computation of diluted net loss per share attributable to ordinary shareholders for the periods presented because including them would have had an anti-dilutive effect were as follows:
Three Months Ended
September 30, 2025
Nine Months Ended
September 30, 2025
Period from September 19, 2024 (Inception) Through September 30, 2024
Convertible preferred stock (as converted to common stock)20,000,000
Outstanding unvested restricted stock units438,386438,386
Outstanding unvested restricted stock awards94,08394,083187,533
Outstanding and issued common stock options4,094,2374,094,237
Total4,626,7064,626,70620,187,533